drugset / Trial / NCT02186275
The Vitamin D in Pediatric Crohn's Disease
Phase 3
Completed
25 enrolled
St. Justine's Hospital
Canadian Institutes of Health Research (CIHR) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine if vitamin D as an adjuvant therapy can improve the outcome (i.e. fewer relapses) and the quality of life, including levels of physical activity, in children with newly diagnosed Crohn's disease (CD).
Timeline
- Start
- 2016-02
- Primary completion
- 2019-12-20
- Completion
- 2019-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 800 iu | Oral |
| Subject | Cholecalciferol | Other / unclassified | 2000 iu | Oral |